Literature DB >> 23274348

Mesenchymal progenitors residing close to the bone surface are functionally distinct from those in the central bone marrow.

Valerie A Siclari1, Ji Zhu, Kentaro Akiyama, Fei Liu, Xianrong Zhang, Abhishek Chandra, Hyun-Duck Nah, Songtao Shi, Ling Qin.   

Abstract

Long bone is an anatomically complicated tissue with trabecular-rich metaphyses at two ends and cortical-rich diaphysis at the center. The traditional flushing method isolates only mesenchymal progenitor cells from the central region of long bones and these cells are distant from the bone surface. We propose that mesenchymal progenitors residing in endosteal bone marrow that is close to the sites of bone formation, such as trabecular bone and endosteum, behave differently from those in the central bone marrow. In this report, we separately isolated endosteal bone marrow using a unique enzymatic digestion approach and demonstrated that it contained a much higher frequency of mesenchymal progenitors than the central bone marrow. Endosteal mesenchymal progenitors express common mesenchymal stem cell markers and are capable of multi-lineage differentiation. However, we found that mesenchymal progenitors isolated from different anatomical regions of the marrow did exhibit important functional differences. Compared with their central marrow counterparts, endosteal mesenchymal progenitors have superior proliferative ability with reduced expression of cell cycle inhibitors. They showed greater immunosuppressive activity in culture and in a mouse model of inflammatory bowel disease. Aging is a major contributing factor for trabecular bone loss. We found that old mice have a dramatically decreased number of endosteal mesenchymal progenitors compared with young mice. Parathyroid hormone (PTH) treatment potently stimulates bone formation. A single PTH injection greatly increased the number of endosteal mesenchymal progenitors, particularly those located at the metaphyseal bone, but had no effect on their central counterparts. In summary, endosteal mesenchymal progenitors are more metabolically active and relevant to physiological bone formation than central mesenchymal progenitors. Hence, they represent a biologically important target for future mesenchymal stem cell studies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23274348      PMCID: PMC3674849          DOI: 10.1016/j.bone.2012.12.013

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  72 in total

1.  Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates.

Authors:  Yusuke Sakaguchi; Ichiro Sekiya; Kazuyoshi Yagishita; Shizuko Ichinose; Kenichi Shinomiya; Takeshi Muneta
Journal:  Blood       Date:  2004-07-08       Impact factor: 22.113

2.  Structure-function relationship of parathyroid hormone: activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells.

Authors:  A Fujimori; S L Cheng; L V Avioli; R Civitelli
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

3.  Differential mesengenic potential and expression of stem cell-fate modulators in mesenchymal stromal cells from human-term placenta and bone marrow.

Authors:  Pamela A Jaramillo-Ferrada; Ernst J Wolvetang; Justin J Cooper-White
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

4.  Intermittent administration of human parathyroid Hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice.

Authors:  A Sakai; T Sakata; S Ikeda; S Uchida; R Okazaki; T Norimura; M Hori; T Nakamura
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

5.  High density micromass cultures of embryonic limb bud mesenchymal cells: an in vitro model of endochondral skeletal development.

Authors:  M A Mello; R S Tuan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-05       Impact factor: 2.416

6.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

7.  Prospective isolation of mesenchymal stem cells from mouse compact bone.

Authors:  Brenton J Short; Nathalie Brouard; Paul J Simmons
Journal:  Methods Mol Biol       Date:  2009

Review 8.  Parathyroid hormone: a double-edged sword for bone metabolism.

Authors:  Ling Qin; Liza J Raggatt; Nicola C Partridge
Journal:  Trends Endocrinol Metab       Date:  2004-03       Impact factor: 12.015

9.  Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential.

Authors:  May Al-Nbaheen; Radhakrishnan Vishnubalaji; Dalia Ali; Amel Bouslimi; Fawzi Al-Jassir; Matthias Megges; Alessandro Prigione; James Adjaye; Moustapha Kassem; Abdullah Aldahmash
Journal:  Stem Cell Rev Rep       Date:  2013-02       Impact factor: 5.739

10.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

View more
  35 in total

1.  Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms.

Authors:  Abhishek Chandra; Tiao Lin; Tiffany Young; Wei Tong; Xiaoyuan Ma; Wei-Ju Tseng; Ina Kramer; Michaela Kneissel; Michael A Levine; Yejia Zhang; Keith Cengel; X Sherry Liu; Ling Qin
Journal:  J Bone Miner Res       Date:  2016-10-20       Impact factor: 6.741

2.  Perivascular osteoprogenitors are associated with transcortical channels of long bones.

Authors:  Sierra H Root; Natalie K Y Wee; Sanja Novak; Clifford J Rosen; Roland Baron; Brya G Matthews; Ivo Kalajzic
Journal:  Stem Cells       Date:  2020-02-21       Impact factor: 6.277

Review 3.  Neural Regulation of Bone and Bone Marrow.

Authors:  Maria Maryanovich; Shoichiro Takeishi; Paul S Frenette
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

4.  The role of CCN family genes in haematological malignancies.

Authors:  J E Wells; M Howlett; L C Cheung; Ursula R Kees
Journal:  J Cell Commun Signal       Date:  2015-05-31       Impact factor: 5.782

5.  Connective Tissue Growth Factor reporter mice label a subpopulation of mesenchymal progenitor cells that reside in the trabecular bone region.

Authors:  Wen Wang; Sara Strecker; Yaling Liu; Liping Wang; Fayekah Assanah; Spenser Smith; Peter Maye
Journal:  Bone       Date:  2014-10-22       Impact factor: 4.398

6.  Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging.

Authors:  Chang-Jun Li; Ye Xiao; Mi Yang; Tian Su; Xi Sun; Qi Guo; Yan Huang; Xiang-Hang Luo
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

7.  Quiescent Bone Lining Cells Are a Major Source of Osteoblasts During Adulthood.

Authors:  Igor Matic; Brya G Matthews; Xi Wang; Nathaniel A Dyment; Daniel L Worthley; David W Rowe; Danka Grcevic; Ivo Kalajzic
Journal:  Stem Cells       Date:  2016-08-29       Impact factor: 6.277

8.  Isolation, selection and culture methods to enhance clonogenicity of mouse bone marrow derived mesenchymal stromal cell precursors.

Authors:  Claas Baustian; Shirley Hanley; Rhodri Ceredig
Journal:  Stem Cell Res Ther       Date:  2015-08-25       Impact factor: 6.832

Review 9.  Hematopoietic stem cell niche maintenance during homeostasis and regeneration.

Authors:  Avital Mendelson; Paul S Frenette
Journal:  Nat Med       Date:  2014-08       Impact factor: 53.440

Review 10.  Mechanical signals protect stem cell lineage selection, preserving the bone and muscle phenotypes in obesity.

Authors:  Danielle M Frechette; Divya Krishnamoorthy; Tee Pamon; M Ete Chan; Vihitaben Patel; Clinton T Rubin
Journal:  Ann N Y Acad Sci       Date:  2017-09-11       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.